Inventor · disambiguated record
Gary Swergold
Also filed as: SWERGOLD GARY · SWERGOLD GARY D
6 granted patents·4 pending applications·138 citations·filing 1989–2019
84Inventor score
Top patents by PatentIndex Score
10 records- 0198US8357371B2Methods for treating hypercholesterolemia using antibodies to PCSK9REGENERON PHARMA·Filed 2011·Granted Jan 22, 2013·89 cites·16 claims
- 0294US9724411B2Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9REGENERON PHARMA·Filed 2013·Granted Aug 8, 2017·15 cites·32 claims
- 0390US11116839B2Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)REGENERON PHARMA·Filed 2018·Granted Sep 14, 2021·6 cites·26 claims
- 0488US10111953B2Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)REGENERON PHARMA·Filed 2014·Granted Oct 30, 2018·15 cites·12 claims
- 0579US10076571B2Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)SWERGOLD GARY·Filed 2012·Granted Sep 18, 2018·8 cites·25 claims
- 0662US2013064834A1Methods for treating hypercholesterolemia using antibodies to pcsk9REGENERON PHARMA·Filed 2012·Application pending·0 cites
- 0761US2019330371A1Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function MutationsREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 0857US2017296657A1Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9REGENERON PHARMA·Filed 2017·Application pending·0 cites
- 0951US2014356370A1Methods for treating autosomal dominant hypercholesterolemia associated with pcsk9 gain-of-function mutationsREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1029US4901381ASupport apparatus for hammocksSWERGOLD GARY D·Filed 1989·Granted Feb 20, 1990·5 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Gary Swergold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →